Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Aggressive Non-Hodgkin's Lymphoma
NCT00201669Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Oct 2004
- Primary completion
- May 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in non-Hodgkin lymphoma (NHL), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Oct 2004; status: completed.
02
Drugs
clofarabine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00201669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201669.